On May 20, 2026, DNA X, Inc. entered a Securities Purchase Agreement, selling a convertible note worth $3,052,787.68 to DNA Holdings Venture, Inc. for cash and surrendering a previous note, with proceeds to be used for working capital. The note matures on December 31, 2026, has a 10% interest rate, and is convertible at $6.00 per share, pending stockholder approval.